Analysts think RVMD stock price could decrease by -1%
Dec 13, 2025, 12:25 PM
0.94%
What does RVMD do
Revolution Medicines, a clinical-stage precision oncology firm based in Redwood City, California, focuses on developing targeted therapies, including RAS(ON) inhibitors and companion inhibitors, currently in clinical development. The company went public on February 13, 2020, and employs 411 staff.
22 analysts think RVMD stock price will decrease by -1.13%. The current median analyst target is $78.03 compared to a current stock price of $78.92. The lowest analysts target is $70.70 and the highest analyst target is $103.95.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.